Staar Surgical [STAA] vs Becton, Dickinson [BDX] Detailed Stock Comparison

Staar Surgical Company

NASDAQ
Loading...

Becton, Dickinson and Company

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Staar Surgical Company wins in 3 metrics, Becton, Dickinson and Company wins in 16 metrics, with 0 ties. Becton, Dickinson and Company appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Staar Surgical Company Becton, Dickinson and Company Better
P/E Ratio (TTM) 49.73 25.40 Becton, Dickinson and Company
Price-to-Book Ratio 3.58 1.75 Becton, Dickinson and Company
Debt-to-Equity Ratio 11.14 77.28 Staar Surgical Company
PEG Ratio -1.07 0.92 Becton, Dickinson and Company
EV/EBITDA -28.99 10.49 Becton, Dickinson and Company
Profit Margin (TTM) -33.60% 8.01% Becton, Dickinson and Company
Operating Margin (TTM) -18.87% 13.35% Becton, Dickinson and Company
EBITDA Margin (TTM) N/A 13.35% N/A
Return on Equity -21.70% 6.96% Becton, Dickinson and Company
Return on Assets (TTM) -5.95% 4.08% Becton, Dickinson and Company
Free Cash Flow (TTM) $-40.05M $2.67B Becton, Dickinson and Company
Dividend Yield N/A 2.56% N/A
1-Year Return 66.10% 8.01% Staar Surgical Company
Price-to-Sales Ratio (TTM) 5.15 2.57 Becton, Dickinson and Company
Enterprise Value $1.08B $63.40B Becton, Dickinson and Company
EV/Revenue Ratio 4.53 2.89 Becton, Dickinson and Company
Gross Profit Margin (TTM) 75.68% 45.91% Staar Surgical Company
Revenue per Share (TTM) $5 $76 Becton, Dickinson and Company
Earnings per Share (Diluted) $-1.62 $6.13 Becton, Dickinson and Company
Beta (Stock Volatility) 1.04 0.35 Becton, Dickinson and Company
Short % of Float 27.18% 3.78% Becton, Dickinson and Company

Staar Surgical Company vs Becton, Dickinson and Company Stock Performance Analysis

Loading Price Chart...

STAA
BDX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Staar Surgical Company0.00%-5.31%-11.54%56.91%20.42%20.21%
Becton, Dickinson and Company-0.49%-2.98%1.43%-9.20%-7.49%-5.04%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Staar Surgical Company66.10%-46.07%-80.50%419.60%454.10%273.29%
Becton, Dickinson and Company8.01%-28.08%-20.73%15.00%123.99%212.28%

Performance & Financial Health Analysis: Staar Surgical Company vs Becton, Dickinson and Company

MetricSTAABDX
Market Information
Market Cap i$1.23B$56.10B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,616,1192,759,250
90 Day Avg. Volume i1,357,9602,521,130
Last Close$28.37$145.52
52 Week Range$15.59 - $35.87$127.59 - $187.35
% from 52W High-20.91%-22.33%
All-Time High$163.08 (Sep 06, 2021)$287.32 (Jul 24, 2023)
% from All-Time High-82.60%-49.35%
Growth Metrics
Quarterly Revenue Growth0.18%0.02%
Quarterly Earnings Growth0.18%0.26%
Financial Health
Profit Margin (TTM) i-0.34%0.08%
Operating Margin (TTM) i-0.19%0.13%
Return on Equity (TTM) i-0.22%0.07%
Debt to Equity (MRQ) i11.1477.28
Cash & Liquidity
Book Value per Share (MRQ)$6.97$88.79
Cash per Share (MRQ)$3.79$2.64
Operating Cash Flow (TTM) i$-34,230,000$3.39B
Levered Free Cash Flow (TTM) i$14.61M$3.11B
Dividends
Last 12-Month Dividend Yield iN/A2.56%
Last 12-Month Dividend iN/A$4.18

Valuation & Enterprise Metrics Analysis: Staar Surgical Company vs Becton, Dickinson and Company

MetricSTAA (Apr 24, 2026)BDX (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i49.7325.40
Forward P/E i32.3611.53
PEG Ratio i-1.070.92
Price to Sales (TTM) i5.152.57
Price to Book (MRQ) i3.581.75
Market Capitalization
Market Capitalization i$1.23B$56.10B
Enterprise Value i$1.08B$63.40B
Enterprise Value Metrics
Enterprise to Revenue i4.532.89
Enterprise to EBITDA i-28.9910.49
Risk & Other Metrics
Beta i1.040.35
Book Value per Share (MRQ) i$6.97$88.79

Financial Statements Comparison: Staar Surgical Company vs Becton, Dickinson and Company

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSTAA (2025)BDX (2025)
Revenue/Sales i239.44M21.84B
Cost of Goods Sold i57.02M11.92B
COGS % of Revenue i23.8%54.6%
Gross Profit i182.42M9.93B
Gross Margin i76.2%45.4%
Research & Development i40.06M1.27B
Operating Income (EBIT) i-45.95M2.99B
Operating Margin i-19.2%13.7%
EBITDA i5.95M5.42B
EBITDA Margin i2.5%24.8%
Pre-Tax Income i-82.26M1.88B
Pre-Tax Income % of Revenue i-34.4%8.6%
Income Tax i-1.82M203.00M
Income Tax % of Revenue i-0.8%0.9%
Net Income (Profit) i-80.45M1.68B
Profit Margin i-33.6%7.7%

Balance Sheet & Liquidity Metrics

MetricSTAA (2025)BDX (2025)
Cash & Equivalents i153.15M641.00M
Total Current Assets i311.55M9.26B
Total Current Assets % of Revenue i130.1%42.4%
Total Current Liabilities i68.50M8.31B
Total Current Liabilities % of Revenue i28.6%38.1%
Long-Term Debt i32.48M17.62B
Long-Term Debt % of Revenue i13.6%80.7%
Total Shareholders Equity i344.18M25.39B
Retained Earnings i-148.02M16.62B
Retained Earnings % of Revenue i-61.8%76.1%
Property, Plant & Equipment i773,0000

Cash Flow Statement Comparison

MetricSTAA (2025)BDX (2025)
Operating Cash Flow i-55.45M3.68B
Operating Cash Flow % of Revenue i-23.2%16.9%
Capital Expenditures i-5.82MN/A
Free Cash Flow i-40.05M2.67B
FCF Margin i-16.7%12.2%
Debt Repayment i-42,000-1.79B
Common Stock Repurchase i-7.98MN/A

Short Interest & Institutional Ownership Analysis

MetricSTAABDX
Shares Short i7.73M9.49M
Short Ratio i6.183.92
Short % of Float i27.18%3.78%
Shares Outstanding i49.40M284.74M
Float Shares i29.79M283.99M
% Held by Insiders i0.60%0.40%
% Held by Institutions i109.60%96.58%
% Held by Public i-10.20%3.02%

Dividend Analysis & Yield Comparison: Staar Surgical Company vs Becton, Dickinson and Company

MetricSTAABDX
Last 12-Month Dividend iN/A$4.18
Last 12-Month Dividend Yield iN/A2.56%
3-Year Avg Annual Dividend iN/A$3.96
3-Year Avg Dividend Yield iN/A0.58%
3-Year Total Dividends iN/A$11.88
Ex-Dividend DateN/AMar 10, 2026